Latest news with #SBC
Time of India
3 days ago
- Sport
- Time of India
EA FC 25 Balde TOTS Honourable Mentions SBC tasks, solutions, and more
Image via EA FC 25 EA FC 25 Balde TOTS Honourable Mentions SBC is a new introduction in the game, and it gives you the opportunity to get a 94-rated card. The Spanish international was unbelievable for FC Barcelona in the 2024/2025 season, being solid both offensively and defensively. By completing the SBC, you can get a fantastic left back in Ultimate Team, and he can also be utilized as a left midfielder. There are a total of seven tasks that you must complete to obtain Balde. Here are all the details about the new Balde TOTS Honourable Mentions SBC in EA FC 25. EA FC 25 Balde TOTS Honourable Mentions SBC tasks The following are the seven tasks that you must complete as part of the Balde TOTS Honourable Mentions SBC in EA FC 25: Task 1 – FC Barcelona Squad rating: Min. 85 No. of players from FC Barcelona: Min. 1 Task 2 – Spain Squad rating: Min. 86 No. of players from Spain: Min. 1 No. of TOTS / TOTW players: Min. 1 Task 3 – Top Form Squad rating: Min. 88 No. of TOTS / TOTW players: Min. 1 Task 4 – 89-Rated Squad Squad rating: Min. 89 Task 5 – 89-Rated Squad Squad rating: Min. 89 Task 6 – 90-Rated Squad Squad rating: Min. 90 Task 7 – 90-Rated Squad Squad rating: Min. 90 You will have to spend around 380 thousand coins to finish all of these tasks for the new Balde SBC in EA FC 25. EA FC 25 Balde TOTS Honourable Mentions SBC cheapest solutions Listed below are the cheapest options for the Balde SBC in EA FC 25: Task 1 – FC Barcelona Iago Aspas 84 Ilestedt 84 Mbock 84 Romero 84 Hakimi 84 Doorsoun 84 Mac Allister 86 Ruben Dias 88 Walker 84 Dani Olmo 84 Vlahovic 84 Task 2 – Spain Griezmann 88 Koulibaly 84 Stones 85 Mane 84 Ake 84 Guirassy 84 Cascarino 84 Nkunku 84 Catarina Macario 84 Mikel Merino 85 Angeldahl 91 Task 3 – Top Form Grealish 84 Laimer 83 Diaz 84 Dovbyk 84 Olga Carmona 83 Prasnikar 84 Neville 83 Hjulmand 93 Boe Risa 93 Iago Aspas 93 Williams 83 Task 4, 5 – 89-Rated Squad Koulibaly 84 Coman 84 Greenwood 84 Aleix Garcia 84 Rodri 91 Mariona 84 Doorsoun 84 Mateo 85 Lavogez 92 Weidauer 93 Goncalo Inacio 93 Task 6, 7 – 90-Rated Squad Kvaratskhelia 85 Stones 85 Brandt 85 Miedema 85 Russo 85 Mikel Merino 85 Schuller 86 Boe Risa 93 Iago Aspas 93 Kokcu 94 Goncalo Inacio 93 If you have fodder cards, you can end up using them for completing the different tasks of the Balde TOTS SBC in EA FC 25. Get IPL 2025 match schedules , squads , points table , and live scores for CSK , MI , RCB , KKR , SRH , LSG , DC , GT , PBKS , and RR . Check the latest IPL Orange Cap and Purple Cap standings.
Borneo Post
6 days ago
- Science
- Borneo Post
Sagah: Tropi named Malaysia's sole partner in global peatland research project
Sagah addresses members of the august House during the DUN sitting today. – Sarawak Public Communications Unit photo KUCHING (May 26): The Sarawak Tropical Peat Research Institute (Tropi) has been appointed as Malaysia's sole partner for the Nitrous Oxide (N2O) Budgets in Peatlands: From Processes to Global Comprehension project this year, said Dato Sri Roland Sagah Wee Inn. The Education, Innovation and Talent Development Minister stated that as part of this collaboration, a Miro Multi-compound Gas Analyser System was deployed at a field site in February to continuously monitor greenhouse gas (GHG) fluxes — specifically Nitrous Oxide (N2O), Carbon Dioxide (CO2), and Methane (CH4). 'To address data transmission challenges from the remote location, the Miro system has been integrated with Starlink satellite internet, enabling real-time, digitised data transfer to Tropi's central repository. 'This setup allows Tropi researchers to continuously access, monitor, and analyse GHG flux data, significantly enhancing the efficiency and responsiveness of their monitoring efforts,' said Sagah during his ministerial winding-up speech at the State Legislative Assembly (DUN) Sitting here today. Sagah said Tropi continues to make substantial contributions to global scientific discourse on peatland conservation and sustainable development in 2025. The institution represented Sarawak at major international platforms, including the International Soil Science Conference 2025, the European Geosciences Union General Assembly (EGU2025), the International Peatland Society Annual Convention 2025, and the 12th Intecol Wetlands Conference. In the speech, Roland highlighted the Sarawak Biodiversity Centre's (SBC) efforts to commercialise biodiversity-based products through a structured and scientific approach. 'This approach involves a progression of registering end products that have traditional claims, to scientifically validated modern health claims and subsequently as pharmaceutical applications,' he said. As a start, SBC is targeting four monographs of local species. 'Monographs are detailed scientific documents that describe the species characteristics, their traditional uses, preparation methods, phytochemical information, pharmacological as well as safety and toxicity of the species. These are important references for registering a product.' He said SBC aims to register these species as natural products with traditional claims with the National Pharmaceutical Regulatory Agency (NPRA) by November 2025. 'If successfully commercialised, these will result in benefit sharing with the communities.' 'Speaking of communities, on May 22 to 24 this year, 46 members from 15 indigenous communities, from 40 locations throughout Sarawak convened at SBC for the annual Traditional Knowledge Documentation Workshop. 'The spotlight of this annual workshop is on prioritising their respective plants and associated traditional knowledge for commercialisation,' he added. Sagah said these initiatives reflect his ministry's commitment to both scientific advancement and sustainable economic development, in line with the international theme for Biodiversity Day 2025, 'Harmony with Nature and Sustainable Development.' 'By recognising the value of traditional knowledge and our biological resources, we are not only committed to sustainable economic growth, but also the preservation of our biodiversity,' he said.
Borneo Post
20-05-2025
- Business
- Borneo Post
Tebedu rep: Amendments to biodiversity ordinance can end biopiracy
KUCHING (May 21): Biopiracy can be prevented and stopped following the amendments to the Sarawak Biodiversity Centre Ordinance, said Dr Simon Sinang Bada (GPS-Tebedu). He said the amendment to Section 6 of the Ordinance opens the door for the Sarawak Biodiversity Council (SBC) to create, develop, apply and own intellectual property rights for all its research and development (R&D) work. '(This) will protect the Council from the threat of potential biopiracy),' he said in his debate supporting the Sarawak Biodiversity Centre (Amendment) Bill 2025 at the Sarawak Legislative Assembly (DUN) yesterday. He also cited the insertion of Section 6A in the amended Ordinance would allow the SBC to incorporate a company to commercialise its research findings. He said this would attract both local and foreign investors to invest in Sarawak, and would greatly contribute and improve Sarawak's socio-economic standing in line with its Post Covid-19 Development Strategy (PCDS) 2030. 'The groundbreaking research and development leveraging our abundant hydropower resources to support The Net Zero and Carbon Plan, and the SAF (Sustainable Aviation Fuel) developed from microalgae is a classic example that requires this Sarawak Biodiversity Centre Bill to be amended accordingly to meet the current needs and requirements. 'The findings from the research could be commercialised to monetise their findings—R&D is an expensive investment. It is right that this investment can be recouped, recovered and for the council to profit from their R&D. The partnering and collaborations with Mitsubishi Corporation had unlocked the full potential of outdoor algae cultivation,' he said. Meanwhile, Dayang Noorazah Awang Sohor (GPS – Lingga) said the amended Ordinance is a critical enabler that empowers the SBC to build upon its existing achievements, effectively pursue its mission, and realise its ambitious vision for the future of biodiversity management in Sarawak. She explained this Bill strengthens the SBC's role as a leading force in conservation and sustainable development, by aligning its capabilities with Sarawak's broader economic and environmental goals. 'For example, imagine the SBC successfully isolated a compound with medicinal properties. This amendment would allow them to patent the compound, license it to a pharmaceutical company, and use the royalties to fund further research into other promising natural resources,' she said in her debate in support of the Bill.
Borneo Post
20-05-2025
- Business
- Borneo Post
Amendments to biodiversity ordinance can end biopiracy
Dr Simon Sinang Bada KUCHING (May 21): Biopiracy can be prevented and stopped following the amendments to the Sarawak Biodiversity Centre Ordinance, said Dr Simon Sinang Bada (GPS – Tebedu). He said the amendment to Section 6 of the Ordinance opens the door for the Sarawak Biodiversity Council (SBC) to create, develop, apply and own intellectual property rights for all its research and development (R&D) work. '(This) will protect the Council from the threat of potential biopiracy),' he said in his debate supporting the Sarawak Biodiversity Centre (Amendment) Bill 2025 at the Sarawak Legislative Assembly (DUN) yesterday. He also cited the insertion of Section 6A in the amended Ordinance would allow the SBC to incorporate a company to commercialise its research findings. He said this would attract both local and foreign investors to invest in Sarawak, and would greatly contribute and improve Sarawak's socio-economic standing in line with its Post Covid-19 Development Strategy (PCDS) 2030. 'The groundbreaking research and development leveraging our abundant hydropower resources to support The Net Zero and Carbon Plan, and the SAF (Sustainable Aviation Fuel) developed from microalgae is a classic example that requires this Sarawak Biodiversity Centre Bill to be amended accordingly to meet the current needs and requirements. 'The findings from the research could be commercialised to monetise their findings—R&D is an expensive investment. It is right that this investment can be recouped, recovered and for the council to profit from their R&D. The partnering and collaborations with Mitsubishi Corporation had unlocked the full potential of outdoor algae cultivation,' he said. Meanwhile, Dayang Noorazah Awang Sohor (GPS – Lingga) said the amended Ordinance is a critical enabler that empowers the SBC to build upon its existing achievements, effectively pursue its mission, and realise its ambitious vision for the future of biodiversity management in Sarawak. She explained this Bill strengthens the SBC's role as a leading force in conservation and sustainable development, by aligning its capabilities with Sarawak's broader economic and environmental goals. 'For example, imagine the SBC successfully isolated a compound with medicinal properties. This amendment would allow them to patent the compound, license it to a pharmaceutical company, and use the royalties to fund further research into other promising natural resources,' she said in her debate in support of the Bill.
Associated Press
20-05-2025
- Business
- Associated Press
SBC Medical's First Quarter Margins Improve; Company Announces Share Buyback Program
By Meg Flippin Benzinga DETROIT, MICHIGAN - May 20, 2025 ( NEWMEDIAWIRE ) - SBC Medical Group Holdings Inc. (NASDAQ: SBC), the Japanese owner and operator of a chain of cosmetic surgery clinics, is in transformation mode, overhauling its pricing structure and adapting to a changing marketplace, which seems to have paid off in the company's first quarter. For the three months ended March 31, 2025, SBC Medical reported earnings per share of $0.21, which was up 5% year-over-year. EBITDA margins were 52%, up from 46% in the year-ago first quarter. The company, which is positioning itself as a leader in the cosmetic surgery market, ended the quarter with 251 clinics, increasing the number by 36 compared to last year's first quarter. Despite a challenging marketplace in Japan, SBC Medical was able to increase its customers in the last twelve months ending in March by 14% to 6.1 million. In a nod to the quality it offers customers at its clinics, SBC Medical also reported that 71% of customers visited franchisee clinics two or more times during the quarter. 'SBC is actively preparing for strategic expansion by enhancing its platform, optimizing its profitability structure, and stabilizing its business through revised pricing strategies and adapting to changing market dynamics,' said Yoshiyuki Aikawa, Chairman and Chief Executive Officer of SBC Medical, when reporting first quarter results. 'In the first quarter of 2025, we were pleased to see the expansion of Medical Corporations (MCs) gaining traction in our franchising, procurement and rental business segments as global demand for aesthetic medical services continued to rise.' SBC Medical Group has been focused on expanding its MCs, which are designed to help cosmetic practitioners operate cosmetic surgery centers and at the same time adhere to regulations. SBC Medical Overhauling For Growth While SBC reported revenue of $47 million in the first quarter - down 14% year-over-year - the company attributed that to the discontinuation of its staffing business and the divestitures of Sky Net Academy and SBC Kijimadaira Resort. Despite that, margins increased, and net income increased 15% year-over-year. 'As we move ahead, we remain confident in our ability to build a scalable franchise model while accelerating expansion across domestic and international markets, driving long-term value for shareholders and positioning the Company to capitalize on future opportunities,' said Aikawa. SBC Medical is working hard to position itself as a leader in the cosmetic surgery market, and it isn't resting on its laurels. To address competition and keep its leading position in the industry, the company is pursuing two strategies: expanding the market by making aesthetic medicine more accessible and appealing to the masses and differentiating itself from the competition by offering advanced treatments and better pricing - bringing its treatments to the U.S. and Singapore. The company is preparing for expansion and says its first quarter results are evidence of that. Buying Back Shares The company underscored its confidence in its growth plan by announcing its board has approved a share buyback program of up to $5 million worth of shares. The buyback program will kick off on May 20, 2025, and last through May 20, 2026. The company is using excess cash and future free cash flow to buy back the shares. SBC Medical said it launched the program because it believes the stock at the current share price undervalues its business performance, growth potential and the aesthetic medical market, including SBC Medical's position. The global cosmetic surgery and procedure market was worth $122.08 billion in 2022, and it is expected to grow at a CAGR of 14.7% from 2023 to 2030. SBC Medical will buy the shares on the open market at prevailing market prices and will continue to look at other ways to enhance the liquidity of its shares. It also plans to issue shares as future stock-based compensation in proportion to the number of repurchased shares. In addition to the repurchase program, SBC Medical says it will continue to consider dividend distributions with the goal of improving its total shareholder return. From expanding the number of clinics to overhauling its pricing to lure new customers and repeat business, SBC Medical is positioning itself to capitalize on what it expects to be growth in the aesthetic medicine market. With a new stock buyback program underway, SBC Medical is showing the world and its investors it has confidence in its growth plans. Featured image sourced fromShutterstock. This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice. This content was originallypublished on further disclosureshere. View the original release on
